Smith & Nephew Highlights Advanced Wound Managemen...( Advanced Wou...),Health

Advanced Wound Management achieves underlying revenues growth of 4% in Q2

St. Petersburg, FL (PRWEB) July 31, 2009 -- Smith & Nephew (LSE: SN; NYSE: SNN) highlights the progress achieved in 2009 by its Advanced Wound Management division. As reported earlier today, Advanced Wound Management's global revenue grew to $208m in the second quarter and $386m for the first half of 2009, increasing by 4% and 6% over the comparable periods of 2008. This growth was driven by gains across its portfolio of strategic brands, RENASYS™ negative pressure wound therapy (NPWT) products, the VERSAJET™ hydrosurgery tool, and ACTICOAT™ and ALLEVYN™ advanced dressings. Revenue from the US grew by 4% YTD.

"Our Advanced Wound Management division continues to be a strong contributor to the group's success," said Dave Illingworth, Chief Executive Officer of Smith & Nephew. "We anticipate continued growth throughout the year, and steady progress with our RENASYS™ line of NPWT products, which was launched in the first half of the year and has made an excellent start."

Smith & Nephew continued its drive to improve customer choice in NPWT by launching RENASYS™ EZ and RENASYS™ GO NPWT pumps in the first quarter. Revenue from the NPWT product range, including RENASYS™ gauze and foam dressings and related disposables, contributed 2% to the division's overall revenue growth in the quarter. The company successfully asserted its IP position in NPWT with particular successes in the United Kingdom and Germany. And leading clinicians brought forward multiple, new research studies using Smith & Nephew NPWT devices at the major wound care, burn and orthopaedic clinical conferences.

The silver coated antimicrobial barrier ACTICOAT™ dressing and sustained antibacterial releasing ALLEVYN™ Ag dressing drove Advanced Woun
'/>"/>